PT1255538E - Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros - Google Patents
Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancrosInfo
- Publication number
- PT1255538E PT1255538E PT01913699T PT01913699T PT1255538E PT 1255538 E PT1255538 E PT 1255538E PT 01913699 T PT01913699 T PT 01913699T PT 01913699 T PT01913699 T PT 01913699T PT 1255538 E PT1255538 E PT 1255538E
- Authority
- PT
- Portugal
- Prior art keywords
- prevention
- methyl
- treatment
- dicarboxylic acid
- satists
- Prior art date
Links
- JCAKCGQZNBEITC-UHFFFAOYSA-N 2-methyl-1,3-thiazolidine-2,4-dicarboxylic acid Chemical compound OC(=O)C1(C)NC(C(O)=O)CS1 JCAKCGQZNBEITC-UHFFFAOYSA-N 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10008159A DE10008159B4 (de) | 2000-02-15 | 2000-02-15 | Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1255538E true PT1255538E (pt) | 2004-03-31 |
Family
ID=7631906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01913699T PT1255538E (pt) | 2000-02-15 | 2001-02-15 | Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6943185B2 (enExample) |
| EP (1) | EP1255538B1 (enExample) |
| JP (1) | JP2003522782A (enExample) |
| CN (1) | CN1400899A (enExample) |
| AT (1) | ATE252383T1 (enExample) |
| AU (1) | AU783933B2 (enExample) |
| CA (1) | CA2399709C (enExample) |
| DE (2) | DE10008159B4 (enExample) |
| EA (1) | EA004592B1 (enExample) |
| ES (1) | ES2208571T3 (enExample) |
| MX (1) | MXPA02007903A (enExample) |
| PL (1) | PL357179A1 (enExample) |
| PT (1) | PT1255538E (enExample) |
| TR (1) | TR200302134T4 (enExample) |
| WO (1) | WO2001060343A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050197406A1 (en) * | 1999-04-14 | 2005-09-08 | Li Chiang J. | Method of treatment of lung cancer |
| DE10008159B4 (de) * | 2000-02-15 | 2005-08-18 | Rudy Dr. Susilo | Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel |
| CN101838218A (zh) * | 2002-02-28 | 2010-09-22 | 日本烟草产业株式会社 | 酯化合物及其医药用途 |
| WO2005021486A1 (ja) * | 2003-08-29 | 2005-03-10 | Japan Tobacco Inc. | エステル誘導体及びその医薬用途 |
| DE102004021658A1 (de) * | 2004-05-03 | 2005-12-01 | Rudy Dr. Susilo | Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure |
| US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| US8101774B2 (en) * | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| AU2005297923B2 (en) * | 2004-10-25 | 2010-12-23 | Japan Tobacco Inc. | Solid medicinal preparation improved in solubility and stability and process for producing the same |
| JP5439849B2 (ja) * | 2008-02-28 | 2014-03-12 | 味の素株式会社 | システイン誘導体 |
| JP5378713B2 (ja) * | 2008-06-19 | 2013-12-25 | 日本理化学薬品株式会社 | 外用組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19711053C2 (de) * | 1997-03-03 | 1999-09-02 | Rommelspacher | Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol |
| DE19711052C2 (de) * | 1997-03-03 | 1999-09-23 | Hans Rommelspacher | Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum |
| DE10008159B4 (de) * | 2000-02-15 | 2005-08-18 | Rudy Dr. Susilo | Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel |
-
2000
- 2000-02-15 DE DE10008159A patent/DE10008159B4/de not_active Expired - Fee Related
-
2001
- 2001-02-15 US US10/182,442 patent/US6943185B2/en not_active Expired - Fee Related
- 2001-02-15 CN CN01805095A patent/CN1400899A/zh active Pending
- 2001-02-15 ES ES01913699T patent/ES2208571T3/es not_active Expired - Lifetime
- 2001-02-15 TR TR2003/02134T patent/TR200302134T4/xx unknown
- 2001-02-15 AT AT01913699T patent/ATE252383T1/de not_active IP Right Cessation
- 2001-02-15 PT PT01913699T patent/PT1255538E/pt unknown
- 2001-02-15 PL PL01357179A patent/PL357179A1/xx not_active Application Discontinuation
- 2001-02-15 EP EP01913699A patent/EP1255538B1/de not_active Expired - Lifetime
- 2001-02-15 AU AU39190/01A patent/AU783933B2/en not_active Ceased
- 2001-02-15 EA EA200200853A patent/EA004592B1/ru not_active IP Right Cessation
- 2001-02-15 WO PCT/DE2001/000656 patent/WO2001060343A2/de not_active Ceased
- 2001-02-15 CA CA002399709A patent/CA2399709C/en not_active Expired - Fee Related
- 2001-02-15 MX MXPA02007903A patent/MXPA02007903A/es active IP Right Grant
- 2001-02-15 DE DE50100833T patent/DE50100833D1/de not_active Expired - Lifetime
- 2001-02-15 JP JP2001559441A patent/JP2003522782A/ja active Pending
-
2005
- 2005-04-29 US US11/117,569 patent/US20050187271A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE252383T1 (de) | 2003-11-15 |
| EP1255538A2 (de) | 2002-11-13 |
| AU783933B2 (en) | 2005-12-22 |
| EA004592B1 (ru) | 2004-06-24 |
| DE50100833D1 (de) | 2003-11-27 |
| DE10008159A1 (de) | 2001-09-06 |
| MXPA02007903A (es) | 2004-09-10 |
| EA200200853A1 (ru) | 2003-02-27 |
| DE10008159B4 (de) | 2005-08-18 |
| US20050187271A1 (en) | 2005-08-25 |
| EP1255538B1 (de) | 2003-10-22 |
| CN1400899A (zh) | 2003-03-05 |
| PL357179A1 (en) | 2004-07-26 |
| WO2001060343A3 (de) | 2002-05-30 |
| TR200302134T4 (tr) | 2004-01-21 |
| ES2208571T3 (es) | 2004-06-16 |
| WO2001060343A2 (de) | 2001-08-23 |
| AU3919001A (en) | 2001-08-27 |
| US6943185B2 (en) | 2005-09-13 |
| US20030149085A1 (en) | 2003-08-07 |
| JP2003522782A (ja) | 2003-07-29 |
| CA2399709A1 (en) | 2001-08-23 |
| CA2399709C (en) | 2007-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03007140A (es) | Derivados de carbolina. | |
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| WO2003080582A3 (de) | Fredericamycin-derivate | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| PT1259512E (pt) | Compostos de pteridin para o tratamento da psoriase | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| EE200300212A (et) | Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks | |
| AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| NO331082B1 (no) | Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft | |
| PT1255538E (pt) | Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros | |
| DE69633396D1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| AU7862401A (en) | Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer | |
| PT1051187E (pt) | Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt) | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
| PL368040A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. |